ID   EGLN1_RAT               Reviewed;         338 AA.
AC   P59722; Q642G6;
DT   16-JUN-2003, integrated into UniProtKB/Swiss-Prot.
DT   26-NOV-2014, sequence version 2.
DT   24-JUL-2024, entry version 141.
DE   RecName: Full=Egl nine homolog 1;
DE            EC=1.14.11.29 {ECO:0000250|UniProtKB:Q9GZT9};
DE   AltName: Full=Hypoxia-inducible factor prolyl hydroxylase 2;
DE            Short=HIF-PH2;
DE            Short=HIF-prolyl hydroxylase 2;
DE            Short=HPH-2;
DE   AltName: Full=Prolyl hydroxylase domain-containing protein 2;
DE            Short=PHD2;
DE   Flags: Fragment;
GN   Name=Egln1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 36-338.
RC   TISSUE=Heart {ECO:0000312|EMBL:AAH81694.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 117-338.
RC   STRAIN=Sprague-Dawley; TISSUE=Glial cell;
RA   Duplan E.;
RT   "Characterization of prolyl hydroxylase EGLN1 in rat C6 glioma cell line.";
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   FUNCTION, AND ACTIVITY REGULATION.
RX   PubMed=12586829; DOI=10.1074/jbc.m211293200;
RA   D'Angelo G., Duplan E., Vigne P., Frelin C.;
RT   "Cyclosporin A prevents the hypoxic adaptation by activating hypoxia-
RT   inducible factor-1alpha Pro-564 hydroxylation.";
RL   J. Biol. Chem. 278:15406-15411(2003).
RN   [5]
RP   ACTIVITY REGULATION, AND INDUCTION.
RX   PubMed=12876291; DOI=10.1074/jbc.m302244200;
RA   D'Angelo G., Duplan E., Boyer N., Vigne P., Frelin C.;
RT   "Hypoxia up-regulates prolyl hydroxylase activity: a feedback mechanism
RT   that limits HIF-1 responses during reoxygenation.";
RL   J. Biol. Chem. 278:38183-38187(2003).
RN   [6]
RP   TISSUE SPECIFICITY, SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=16765982; DOI=10.1016/j.yjmcc.2006.04.009;
RA   Willam C., Maxwell P.H., Nichols L., Lygate C., Tian Y.M., Bernhardt W.,
RA   Wiesener M., Ratcliffe P.J., Eckardt K.U., Pugh C.W.;
RT   "HIF prolyl hydroxylases in the rat; organ distribution and changes in
RT   expression following hypoxia and coronary artery ligation.";
RL   J. Mol. Cell. Cardiol. 41:68-77(2006).
CC   -!- FUNCTION: Cellular oxygen sensor that catalyzes, under normoxic
CC       conditions, the post-translational formation of 4-hydroxyproline in
CC       hypoxia-inducible factor (HIF) alpha proteins. Hydroxylates a specific
CC       proline found in each of the oxygen-dependent degradation (ODD) domains
CC       (N-terminal, NODD, and C-terminal, CODD) of HIF1A. Also hydroxylates
CC       HIF2A. Has a preference for the CODD site for both HIF1A and HIF1B.
CC       Hydroxylated HIFs are then targeted for proteasomal degradation via the
CC       von Hippel-Lindau ubiquitination complex. Under hypoxic conditions, the
CC       hydroxylation reaction is attenuated allowing HIFs to escape
CC       degradation resulting in their translocation to the nucleus,
CC       heterodimerization with HIF1B, and increased expression of hypoxy-
CC       inducible genes. EGLN1 is the most important isozyme under normoxia
CC       and, through regulating the stability of HIF1, involved in various
CC       hypoxia-influenced processes such as angiogenesis in retinal and
CC       cardiac functionality. Target proteins are preferentially recognized
CC       via a LXXLAP motif. {ECO:0000250|UniProtKB:Q9GZT9,
CC       ECO:0000269|PubMed:12586829}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate + L-prolyl-[hypoxia-inducible factor alpha
CC         subunit] + O2 = CO2 + succinate + trans-4-hydroxy-L-prolyl-[hypoxia-
CC         inducible factor alpha subunit]; Xref=Rhea:RHEA:48400, Rhea:RHEA-
CC         COMP:12093, Rhea:RHEA-COMP:12094, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16526, ChEBI:CHEBI:16810, ChEBI:CHEBI:30031,
CC         ChEBI:CHEBI:50342, ChEBI:CHEBI:61965; EC=1.14.11.29;
CC         Evidence={ECO:0000250|UniProtKB:Q9GZT9};
CC   -!- COFACTOR:
CC       Name=Fe(2+); Xref=ChEBI:CHEBI:29033;
CC         Evidence={ECO:0000250|UniProtKB:Q9GZT9,
CC         ECO:0000255|PROSITE-ProRule:PRU00805};
CC       Note=Binds 1 Fe(2+) ion per subunit. {ECO:0000250|UniProtKB:Q9GZT9,
CC       ECO:0000255|PROSITE-ProRule:PRU00805};
CC   -!- COFACTOR:
CC       Name=L-ascorbate; Xref=ChEBI:CHEBI:38290;
CC         Evidence={ECO:0000250|UniProtKB:Q9GZT9};
CC   -!- ACTIVITY REGULATION: Increased activation in hypoxia. Hydroxylation of
CC       the C-terminal ODD domain (CODD) proline of HIF1A is activated by
CC       cyclosporin A (CsA). {ECO:0000269|PubMed:12586829,
CC       ECO:0000269|PubMed:12876291}.
CC   -!- SUBUNIT: Monomer. Interacts with ING4; the interaction inhibits the
CC       hydroxylation of HIF alpha proteins. Interacts with PTGES3 (via PXLE
CC       motif); thereby recruiting EGLN1 to the HSP90 pathway to facilitate HIF
CC       alpha proteins hydroxylation. Interacts with LIMD1. Found in a complex
CC       composed of LIMD1, VHL, EGLN1/PHD2, ELOB and CUL2. Interacts with
CC       EPAS1. Interacts with CBFA2T3 and HIF1A.
CC       {ECO:0000250|UniProtKB:Q9GZT9}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16765982}. Nucleus
CC       {ECO:0000269|PubMed:16765982}. Note=Mainly cytoplasmic. Shuttles
CC       between the nucleus and cytoplasm. Nuclear export requires functional
CC       XPO1. {ECO:0000250|UniProtKB:Q9GZT9}.
CC   -!- TISSUE SPECIFICITY: Expressed in heart, liver, kidney, brain, liver and
CC       testis. Highest levels in heart, lowest in liver.
CC       {ECO:0000269|PubMed:16765982}.
CC   -!- INDUCTION: Up-regulated by hypoxia especially in liver and testis.
CC       Levels up-regulated also in myocardial infarction predominantly in
CC       cardiomyocytes. {ECO:0000269|PubMed:12876291,
CC       ECO:0000269|PubMed:16765982}.
CC   -!- DOMAIN: The beta(2)beta(3) 'finger-like' loop domain is important for
CC       substrate (HIFs' CODD/NODD) selectivity.
CC       {ECO:0000250|UniProtKB:Q9GZT9}.
CC   -!- PTM: S-nitrosylation inhibits the enzyme activity up to 60% under
CC       aerobic conditions. Chelation of Fe(2+) has no effect on the S-
CC       nitrosylation. It is uncertain whether nitrosylation occurs on Cys-238
CC       or Cys-241. {ECO:0000250|UniProtKB:Q9GZT9}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC081694; AAH81694.1; -; mRNA.
DR   EMBL; AY228140; AAO34711.1; -; mRNA.
DR   RefSeq; XP_002725482.2; XM_002725436.3.
DR   AlphaFoldDB; P59722; -.
DR   SMR; P59722; -.
DR   BioGRID; 259192; 1.
DR   STRING; 10116.ENSRNOP00000026767; -.
DR   BindingDB; P59722; -.
DR   ChEMBL; CHEMBL3638322; -.
DR   PhosphoSitePlus; P59722; -.
DR   jPOST; P59722; -.
DR   PaxDb; 10116-ENSRNOP00000026767; -.
DR   UCSC; RGD:631375; rat.
DR   AGR; RGD:631375; -.
DR   RGD; 631375; Egln1.
DR   eggNOG; KOG3710; Eukaryota.
DR   InParanoid; P59722; -.
DR   OrthoDB; 5358684at2759; -.
DR   BRENDA; 1.14.11.29; 5301.
DR   Reactome; R-RNO-1234176; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0014069; C:postsynaptic density; ISO:RGD.
DR   GO; GO:0016706; F:2-oxoglutarate-dependent dioxygenase activity; ISO:RGD.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0008198; F:ferrous iron binding; ISS:UniProtKB.
DR   GO; GO:0160082; F:hypoxia-inducible factor-proline dioxygenase activity; ISO:RGD.
DR   GO; GO:0031418; F:L-ascorbic acid binding; IEA:UniProtKB-KW.
DR   GO; GO:0031545; F:peptidyl-proline 4-dioxygenase activity; IBA:GO_Central.
DR   GO; GO:0031543; F:peptidyl-proline dioxygenase activity; IDA:RGD.
DR   GO; GO:0055008; P:cardiac muscle tissue morphogenesis; ISO:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IBA:GO_Central.
DR   GO; GO:0060347; P:heart trabecula formation; ISO:RGD.
DR   GO; GO:0006879; P:intracellular iron ion homeostasis; ISO:RGD.
DR   GO; GO:0032364; P:intracellular oxygen homeostasis; ISO:RGD.
DR   GO; GO:0060711; P:labyrinthine layer development; ISO:RGD.
DR   GO; GO:1905290; P:negative regulation of CAMKK-AMPK signaling cascade; IMP:RGD.
DR   GO; GO:0051344; P:negative regulation of cyclic-nucleotide phosphodiesterase activity; IMP:BHF-UCL.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:RGD.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IDA:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0045765; P:regulation of angiogenesis; ISS:UniProtKB.
DR   GO; GO:0099159; P:regulation of modification of postsynaptic structure; ISO:RGD.
DR   GO; GO:0140252; P:regulation protein catabolic process at postsynapse; ISO:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IDA:RGD.
DR   GO; GO:0071731; P:response to nitric oxide; ISS:UniProtKB.
DR   GO; GO:0060412; P:ventricular septum morphogenesis; ISO:RGD.
DR   Gene3D; 2.60.120.620; q2cbj1_9rhob like domain; 1.
DR   InterPro; IPR051559; HIF_prolyl_hydroxylases.
DR   InterPro; IPR005123; Oxoglu/Fe-dep_dioxygenase.
DR   InterPro; IPR006620; Pro_4_hyd_alph.
DR   InterPro; IPR044862; Pro_4_hyd_alph_FE2OG_OXY.
DR   PANTHER; PTHR12907:SF4; EGL NINE HOMOLOG 1; 1.
DR   PANTHER; PTHR12907; EGL NINE HOMOLOG-RELATED; 1.
DR   Pfam; PF13640; 2OG-FeII_Oxy_3; 1.
DR   SMART; SM00702; P4Hc; 1.
DR   PROSITE; PS51471; FE2OG_OXY; 1.
PE   2: Evidence at transcript level;
KW   Cytoplasm; Dioxygenase; Iron; Metal-binding; Nucleus; Oxidoreductase;
KW   Phosphoprotein; Reference proteome; S-nitrosylation; Vitamin C.
FT   CHAIN           <1..338
FT                   /note="Egl nine homolog 1"
FT                   /id="PRO_0000206663"
FT   DOMAIN          209..307
FT                   /note="Fe2OG dioxygenase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00805"
FT   REGION          1..99
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          156..166
FT                   /note="Beta(2)beta(3) 'finger-like' loop"
FT                   /evidence="ECO:0000250|UniProtKB:Q9GZT9"
FT   COMPBIAS        1..17
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        58..72
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         228
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /evidence="ECO:0000250|UniProtKB:Q9GZT9,
FT                   ECO:0000255|PROSITE-ProRule:PRU00805"
FT   BINDING         230
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /evidence="ECO:0000250|UniProtKB:Q9GZT9,
FT                   ECO:0000255|PROSITE-ProRule:PRU00805"
FT   BINDING         289
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /evidence="ECO:0000250|UniProtKB:Q9GZT9,
FT                   ECO:0000255|PROSITE-ProRule:PRU00805"
FT   BINDING         298
FT                   /ligand="2-oxoglutarate"
FT                   /ligand_id="ChEBI:CHEBI:16810"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00805"
FT   MOD_RES         52
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9GZT9"
FT   MOD_RES         116
FT                   /note="S-nitrosocysteine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9GZT9"
FT   MOD_RES         123
FT                   /note="S-nitrosocysteine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9GZT9"
FT   MOD_RES         217
FT                   /note="S-nitrosocysteine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9GZT9"
FT   MOD_RES         238
FT                   /note="S-nitrosocysteine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9GZT9"
FT   MOD_RES         241
FT                   /note="S-nitrosocysteine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9GZT9"
FT   CONFLICT        36
FT                   /note="T -> R (in Ref. 2; AAH81694)"
FT                   /evidence="ECO:0000305"
FT   NON_TER         1
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   338 AA;  36093 MW;  B82FF7AA0417198B CRC64;
     PRAQPAPAQP RVAPPPGGAP GAARAGGAAR RGDSSTAASR VPGPEDATQA GSGPGPAEPS
     SEDPPPSRSP GPERASLCPA GGGPGEALSP SGGLRPNGQT KPLPALKLAL EYIVPCMNKH
     GICVVDDFLG RETGQQIGDE VRALHDTGKF TDGQLVSQKS DSSKDIRGDK ITWIEGKEPG
     CETIGLLMSS MDDLIRHCSG KLGNYRINGR TKAMVACYPG NGTGYVRHVD NPNGDGRCVT
     CIYYLNKDWD AKVSGGILRI FPEGKAQFAD IEPKFDRLLF FWSDRRNPHE VQPAYATRYA
     ITVWYFDADE RARAKVKYLT GEKGVRVELK PNSVSKDV
//
